NeonMind Biosciences Inc.: NeonMind Engages Leading Digital Platform for Medical Education and Adoption of Ketamine Treatments in Preparation of Opening its Inaugural Specialty Mental Health Clinic
Initiates Medical Adoption Program with Impetus Digital, a Leading Healthcare Platform for Virtual Medical EducationOAKVILLE, ON / ACCESSWIRE / April 19, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBD)(FRA:6UF)
Rob Tessarolo Insite Touchpoints Neonmind Biosciences Inc Canadian Securities Exchange Initiates Medical Adoption Program Impetus Digital
Source: finanznachrichten.de